nuclear medicine cooperation

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production

NRG|PALLAS and Curium Expand Cooperation in Lu-177 Production NRGIPALLAS (ENS Corporate Member) and Curium have signed a long-term agreement to expand the current cooperation to include the production of lutetium-177 (Lu-177). This agreement will enable Curium to supply about 70,000 doses of Lu-177 annually, which will help about 14,000 patients per year. Curium and NRG…

nuclear medicine supply chain production

NRG|PALLAS and TAG1 Inc. Partner To Expand Pb-212 Production

NRG|PALLAS and TAG1 Inc. Partner To Expand Pb-212 Production NRGIPALLAS (ENS Corporate Member) and TAG1 Inc. have signed a multi-year partnership to secure a critical supply of radium-224 for the production of lead-212 (Pb-212) isotope. This agreement aims to strengthen the supply chain for innovative radiopharmaceutical cancer treatments, including Targeted Alpha Therapies (TATs), which hold great…

Urenco TU Delft Talents

Urenco and TU Delft Support New Nuclear Talents

Urenco and TU Delft Support New Nuclear Talents Urenco (ENS Corporate Member) and Dutch university TU Delft are teaming up to develop new generations of nuclear scientists. Urenco is supporting the Delft Excellent Laboratory Facilities for Innovation and Nuclear Education (DELFINE) programme for three years to increase the pool of nuclear talent who can work…

NRG PALLAS

Steps Forward for the PALLAS Reactor

Steps Forward for the PALLAS Reactor NRG PALLAS (ENS Corporate Member) announced the completion of the construction pit and the foundation, marking the end of this phase of the PALLAS project. This has laid the foundation for the next phase of construction. The arrival of the PALLAS-reactor is crucial for the production of medical isotopes.…

nuclear medicine cooperation

NRG PALLAS and Curium Sustain Continuity in the Global Supply of Mo-99

NRG PALLAS and Curium Sustain Continuity in the Global Supply of Mo-99 NRG PALLAS (ENS Corporate Member) and Curium have recently extended their collaboration for the production of molybdenum-99, which decays into technetium-99m, through a new multi-year agreement, essential to ensure the continuity of medical isotope supply. This agreement underlines the shared dedication of both partners…